Skip to content
HowShorted

Tvardi Therapeutics, Inc. short interest in 2026

In 2026, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 5.84% of shares outstanding on 15 Jan 2026 to 1.92% on 15 Sep 2026, a change of -3.92 percentage points. The year's high was 7.87% on 13 Feb 2026 and its low 1.30% on 14 Aug 2026, averaging 5.08% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.05 days on 13 Mar 2026. Full history: Tvardi Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tvardi Therapeutics, Inc. in 2026

2026 in figures

Start of year
5.84% (15 Jan 2026)
End of year
1.92% (15 Sep 2026)
Change
-3.92 pp
High
7.87% (13 Feb 2026)
Low
1.30% (14 Aug 2026)
Average
5.08%
Highest days to cover
16.05 (13 Mar 2026)
SEC filings marked
6

Every report in 2026

Tvardi Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20265.84%4.42
30 Jan 20267.08%13.20
13 Feb 20267.87%11.89
27 Feb 20266.79%15.22
13 Mar 20267.13%16.05
31 Mar 20266.97%13.3710-K filed, results (8-K)
15 Apr 20265.91%8.07
30 Apr 20265.43%14.85
15 May 20265.22%11.0910-Q filed, results (8-K)
29 May 20264.65%7.99
15 Jun 20264.24%6.88
30 Jun 20265.41%1.00
15 Jul 20265.79%1.00
31 Jul 20262.80%1.00
14 Aug 20261.30%1.0010-Q filed, results (8-K)
31 Aug 20261.99%1.87
15 Sep 20261.92%2.29

See also: Tvardi Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.